Syntagon Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Syntagon General Information

Description

Manufacturer and developer of drugs and chemicals. The company involved in contract development and manufacturing organization (CDMO) and testing pharmaceutical ingredients supporting clinical trials and launched products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Primary Office
  • Box 2073
  • 151 02 Södertälje
  • Sweden
+46 08-554 000 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Syntagon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Syntagon‘s full profile, request access.

Request a free trial

Syntagon Executive Team (2)

Name Title Board Seat Contact Info
Michael Lofthagen Chief Executive Officer & Co-Founder
Paul Alhadeff Co-Founder & General Manager
To view Syntagon’s complete executive team members history, request access »

Syntagon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial